Cover Image

Associations between coexposure to bisphenols mixture and metabolic diseases: based on three statistical models

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Yaqi Zhu, Keqin Liu, Jinjin Guo, Yuqi Wang, Jixin Yang, Yanwei Su
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Obesity
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive Value of C‐Reactive Protein/Albumin Ratio for Necrotizing Enterocolitis in Preterm Infants With Neonatal Sepsis
by: Keqin Liu, et al.
Published: (2025)

Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study
by: Hai‐Yang Yuan, et al.
Published: (2024)

Association of obesity or metabolic syndrome with various allergic diseases: An overview of reviews
by: Yasutaka Kuniyoshi, et al.
Published: (2024)

Association between metabolic syndrome and risk of cardiovascular disease among postmenopausal women: A cohort study
by: Jintao Tao, et al.
Published: (2025)

Association between transitions in metabolic health and colorectal cancer across categories of body size phenotype: a prospective cohort study
by: Qian Liu, et al.
Published: (2024)

Associations between paediatric obesity, chemical mixtures and environmental factors, in a national cross‐sectional study of Canadian children
by: Rose Dugandzic, et al.
Published: (2024)

Branched‐chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases
by: Shama Mansoori, et al.
Published: (2024)

Iron overload is closely associated with metabolic dysfunction‐associated fatty liver disease in type 2 diabetes
by: Huanjia Qu, et al.
Published: (2025)

The various associations between whole /regional fat mass and trajectory of cardiometabolic diseases: a nonlinear multistate model
by: Xinming Xu, et al.
Published: (2024)

Associations of short‐term changes in obesity indices with all‐cause mortality and cardiovascular disease
by: Lyu Wang, et al.
Published: (2024)

Dopamine in the regulation of glucose and lipid metabolism: a narrative review
by: Zhehong Li, et al.
Published: (2024)

Impact of metabolic phenotype changes on the development of chronic kidney disease: Panasonic cohort study 17
by: Junya Hironaka, et al.
Published: (2025)

An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
by: Zhuolin Zhou, et al.
Published: (2025)

Amino acid metabolism modulates chronic kidney disease progression by mediating the aging process: Mechanistic insights and therapeutic interventions
by: Yi Song, et al.
Published: (2026)

Genetic and environmental contributions to the associations between midlife personality and late‐life metabolic health
by: Colin D. Freilich, et al.
Published: (2025)

Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management
by: Jiten Vora, et al.
Published: (2024)

The correlation of apolipoprotein B and apolipoprotein A1 with metabolic dysfunction‐associated steatotic liver disease in children and adolescents with obesity
by: Xiao‐Yan Shi, et al.
Published: (2025)

Association of overweight/obesity and overweight/obesity‐related metabolic dysfunction‐associated steatotic liver disease in young adults with coronary artery calcification later in life
by: Jia‐Jie Wang, et al.
Published: (2024)

Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases
by: Hao Hong, et al.
Published: (2024)

Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
by: Wenxiao Fan, et al.
Published: (2025)

Machine learning‐based clustering identifies obesity subgroups with differential multi‐omics profiles and metabolic patterns
by: Mohammad Y. Anwar, et al.
Published: (2024)

Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system
by: Ning Wang, et al.
Published: (2026)

High‐intensity interval training induces lactate dehydrogenase B lactylation to inhibit hepatic lipogenesis to alleviate metabolic dysfunction‐associated fatty liver disease
by: Wenhua Huang, et al.
Published: (2026)

Associations between obesity and severity of coronavirus disease 2019 in Brazilian inpatients: A 2021 secondary data analysis
by: Gabrielle Ribeiro Sena, et al.
Published: (2024)

Non‐invasive diagnosis of metabolic dysfunction‐associated steatotic liver disease: Current status, challenges, and future directions
by: Yuqing Ma, et al.
Published: (2025)

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
by: Yaxin Wang, et al.
Published: (2024)

Association between psychological resilience and body mass index in a community‐based population: A cross‐sectional study
by: Nan Zheng, et al.
Published: (2024)

Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
by: Gong Feng, et al.
Published: (2024)

Association between estimated glucose disposal rate and lower extremity arterial disease in type 2 diabetes: A nationwide cross‐sectional study from China
by: Xiaowei Wei, et al.
Published: (2025)

Caution in interpreting imaging‐based rankings in network meta‐analyses of metabolic dysfunction–associated steatotic liver disease therapies
by: Seoung Hoon Kim
Published: (2026)

Association between the changes in the estimated glucose disposal rate and new‐onset cardiovascular disease in middle‐aged and elderly individuals: A nationwide prospective cohort study in China
by: Lunqing Yan, et al.
Published: (2025)

The association of ultra‐processed food intake with adolescent metabolic dysfunction‐associated steatotic liver disease in the NHANES
by: Maarten Buytaert, et al.
Published: (2024)

Food insecurity is a risk factor for metabolic dysfunction‐associated steatotic liver disease in Latinx children
by: Sarah L. Maxwell, et al.
Published: (2024)

Relationship between cardiometabolic index and worsening renal function in T2DM : Insights from machine learning, growth mixture modelling, and development of a web‐based risk prediction tool
by: Quan Zhang, et al.
Published: (2025)

The epigenetic mechanism of metabolic risk in bipolar disorder
by: Kexin Huang, et al.
Published: (2024)

Worldwide burden of metabolic risk‐related cardiovascular disease from 1990 to 2021, with projections to 2050: A systematic analysis for the Global Burden of Disease Study 2021
by: Xinjiang Dong, et al.
Published: (2025)

The association of breastfeeding duration on metabolic syndrome among children and adolescents, stratified by birth weight for gestational age
by: Wen Yuan, et al.
Published: (2024)

Comment on “Associations between gestational diabetes and cardiovascular disease largely operate independently of postpartum causal pathways: A population‐based cohort study in England”
by: S. Dhanya Dedeepya, et al.
Published: (2025)

Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction‐associated steatotic liver disease: Post hoc analysis of three randomised controlled trials
by: Matthew J. Armstrong, et al.
Published: (2024)

Empagliflozin mitigates metabolic dysfunction‐associated steatotic liver disease by reducing de novo lipogenesis in a mouse model of lipoatrophic diabetes
by: Sarra Smati, et al.
Published: (2024)